SCHEMBL22167213

SCHEMBL22167213

CCCC1CCC(C2CC=C(c3cnc(-c4ccc(CC(NC(=O)c5ccc(CC)s5)C(=O)N5CC(C(O)O)C5)cc4)nc3)CC2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22167427 0.92 PYGL (0.31) —
SCHEMBL17492904 0.92 PYGL (0.31) —
SCHEMBL17492905 0.92 PYGL (0.31) —
SCHEMBL22167394 0.87 S1PR1 (0.34) —
SCHEMBL17532367 0.87 S1PR1 (0.34) —
SCHEMBL17532297 0.87 S1PR1 (0.34) —
SCHEMBL23838969 0.87 F2 (0.32) —
SCHEMBL20026802 0.87 F2 (0.32) —
SCHEMBL23839024 0.87 F2 (0.32) —
SCHEMBL17532348 0.87 F2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3172199-B1 PYRIMIDINE DERIVATIVES AS GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-07-01 — — EP disclosed
Send feedback